Results 121 to 130 of about 185,906 (291)

A psoriasis modern terápiás lehetőségei

, 2018
A pikkelysömör (psoriasis) egy igen gyakori, krónikus lefolyású, nem fertőző, immunológiai gyulladás által kiváltott bőrbetegség. Legfőbb jellemzője a bőrfelszínen megjelenő vörös színű, fehéren hámló, több centiméter nagyságú papulák és plakkok ...
Fábián, Fiona
core  

The pharmacological treatment of psoriasis

, 2022
Psoriasis is a chronic, multisystemic, autoimmune disease with an unknown etiology that can severely affect patients’ lives. Chronic inflammation is the hallmark of the disease, with treatments aimed at decreasing the immune response either locally or ...
Tzikinovsky, Yair
core  

Investigating the changes in skin color representation within US medical textbook imagery

Anatomical Sciences Education, EarlyView.
Abstract Medical education traditionally relies on textbooks with limited representation of dark skin tones, contributing to “visual racism.” This study sought to answer: “To what extent has skin‐of‐color representation changed in widely used U.S. medical textbooks over twenty years?” Older and newer editions of four widely used medical textbooks were ...
Justin Lyon, Dillon Stevens, Adriene Pavek, Annabelle Huntsman, Jennifer L. Hamilton   +4 more
wiley   +1 more source

Effectiveness of baricitinib in acquired reactive perforating collagenosis: a case report

Frontiers in Immunology
BackgroundAcquired reactive perforating collagenosis (ARPC) poses a clinical challenge with an unclear pathogenesis. This disease has been frequently proven resistant to immunosuppressive treatments, significantly affecting the quality of life of ...
Jianfeng Zheng, Jianfeng Zheng, Yangfeng Ding, Yangfeng Ding, Yuanyuan Chen, Yuanyuan Chen, Yuling Shi, Yuling Shi, Yunlu Gao, Yunlu Gao   +9 more
doaj   +1 more source

Analysis of Factors Influencing Clinical Types of Psoriasis Vulgaris [PDF]

, 2008
Background: Psoriasis is a chronic relapsing disorder which is influenced by various external factors. Korean psoriasis vulgaris are characterized by smaller sized plaques than those of Western population and this type of psoriasis was reported to be ...
유욱
core  

Long‐Term Risk of Rheumatoid Arthritis in Individuals With Autism Spectrum Disorder: A Population‐Based Matched Cohort Study

Autism Research, EarlyView.
ABSTRACT To investigate the long‐term risk of rheumatoid arthritis (RA) among individuals with autism spectrum disorder (ASD), addressing potential immune comorbidity in ASD populations. A population‐based matched cohort was assembled using Swedish registers, including 46,164 individuals diagnosed with ASD between 1987 and 2017, matched to 4,634,895 ...
Evora Hailin Zhu, Stephen Z. Levine, Matilda Morin, Weiyao Yin, Benjamin Christofferson, Johan Askling, Natalia Rivera, Abraham Reichenberg, Joseph D. Buxbaum, Sven Sandin, Benjamin Hon Kei Yip   +10 more
wiley   +1 more source

Outcomes and risk factors of COVID-19 in patients with bullous pemphigoid: a cross-sectional study

Frontiers in Immunology
BackgroundThe outcomes of coronavirus disease 2019 (COVID-19) in patients with bullous pemphigoid (BP) remain insufficiently understood. This study aimed to evaluate the impact of COVID-19 on BP patients and identify factors influencing the risk and ...
Yuexin Zhang, Yuexin Zhang, Dawei Huang, Dawei Huang, Yuling Shi, Yuling Shi, Yangfeng Ding, Yangfeng Ding, Yunlu Gao, Yunlu Gao   +9 more
doaj   +1 more source

Psoriasis terápiája, ápolása, gondozása osztályunkon

, 2016
Szakdolgozatomban a psoriasis bőrbetegséget szeretném bemutatni, illetve több oldalról megközelíteni, hiszen egy nagyon komplex összetevőjű kórképről van szó, melynek kialakulásában a genetikai, immunológiai, életmódbeli és pszichés hatások együttes ...
Hegyi-Kecsmár, Diána
core  

Statin Use and Psoriasis Severity

, 2010
Background Inflammation plays a key role in psoriasis. Statins reduce inflammatory markers. However, data in the literature are limited regarding the effect of statins in psoriasis patients.
Perry, Adam, Kamalpour, Loebat, Suephy C. Chen, Loebat Kamalpour, Veledar, Emir, Chen, Suephy C., Emir Veledar, Adam Perry   +7 more
core   +1 more source

First‐in‐human, phase I, randomized, safety, pharmacokinetic, food‐effect and pharmacodynamic study of a tyrosine kinase 2/Janus kinase 1 inhibitor, SDC‐1801

British Journal of Clinical Pharmacology, EarlyView.
Aim The purpose of this study is to evaluate safety, tolerability, pharmacokinetics (PK), food‐effect (FE) and pharmacodynamics (PD) of an oral tyrosine kinase‐2 (TYK2)/Janus kinase‐1 (JAK1) inhibitor, SDC‐1801, in healthy adult participants. Methods This first‐in‐human study randomized 95 male and female participants.
Chris Brearley, Sam Francis, John Reader, Judi Proctor   +3 more
wiley   +1 more source